Related Experiment Videos
N-myc oncogene amplification in paediatric tumours
1Children's Research Centre, Our Lady's Hospital for Sick Children, Crumlin, Dublin, Ireland.
Irish Journal of Medical Science
|June 1, 1990
Summary
N-myc gene amplification in paediatric tumours indicates aggressive properties. This finding extends beyond neuroectodermal origins, suggesting broader implications for embryonal tumour development and treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The N-myc proto-oncogene is implicated in the development of certain paediatric cancers.
- Understanding N-myc's role is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate N-myc gene amplification in paediatric tumours.
- To determine if N-myc amplification correlates with tumour aggressiveness.
Main Methods:
- DNA was extracted from 29 paediatric tumour samples (neuroblastoma, Wilms tumour, miscellaneous).
- N-myc amplification was assessed using the pNb-1 recombinant plasmid.
- Tumour stages and histology were analyzed in relation to N-myc copy number.
Main Results:
- N-myc amplification (≥15 copies) was found in 4 neuroblastoma patients, correlating with advanced stage.
- Low-grade N-myc amplification (2-5 copies) was observed in 3 neuroblastoma patients and one Wilms tumour patient.
- Single-copy N-myc levels were present in all other tumours.
Conclusions:
- N-myc gene amplification confers aggressive characteristics on various embryonal tumours.
- This phenomenon is not limited to neuroectodermal tumours.
- Further research into oncogene interactions may improve neuroblastoma treatment.